ASPET NEUs is a blog written and produced by students and trainees within ASPET NEU. This blog will highlight some of the amazing scientific work of Neuropharmacologists nationwide.
Biweekly posts include stories on:
- research advances
- profiles of scientists
- Neuropharmacology-related events
- Potential applications of Neuropharmacology research for improving the health and well-being of people.
Our writers are graduate students who carry out independent research in fields related Neuropharmacology.
If you are an ASPET member and would like to become a contributor, please contact Luisa Torres at email@example.com.
November 01, 2019
"To introduce undergraduate students to pharmacology research and to use authentic, mentored research experiences in pharmacology to heighten student interest in careers in research and related health care disciplines." That is the vision of the ASPET SURF program and the same vision that the University of Cincinnati (UC) adopts when conducting its own SURF program each year.
September 17, 2019
Dr. Wisam Toma spends his time sneaking up on mice and poking them when they’re not looking.
July 12, 2019
Individually, PhD’s and MD’s can accomplish amazing things, but bring the two groups together for a common cause and their potential to succeed is limitless.
June 20, 2019
Dr. Robert Gould will open the doors to his new laboratory this summer in the department of Physiology and Pharmacology at the Wake Forest School of Medicine.
June 12, 2019
Are lab-made marijuana-like compounds a safe medicine or a deadly drug of abuse? Between evening news stories about epileptic children who appear cured after consuming marijuana extracts, juxtaposed with stories of lab-made marijuana-like compounds causing mass psychosis, the picture is not clear.
May 29, 2019
Not seeing much information out in the internet about what the profile of a scientist-entrepreneur looks like, I decided to do my first blog post interviewing one. Dr. Rodriguez Orengo is a prolific researcher in Puerto Rico, a role model, and a self-described scientist-entrepreneur.
May 22, 2019
If someone would ask you whether cancer and neurodegenerative disorders have anything in common, what would you answer? After meeting with Dr. David Talmage, I was able to learn more about Neuregulin/ErbB signaling pathway, and its significance in both cancer and neuroscience fields.
May 09, 2019
Psychedelics have gained massive media attention in recent years and their reputation is in the midst of a dramatic renaissance.
April 24, 2019
Why do some people become alcoholics while others don’t? Finding the answer is like finding a needle in a haystack.
April 09, 2019
ASPET’s Division of Neuropharmacology is excited to present Dr. Michelle Mazei-Robison with the 2019 Early Career Investigator Award.
November 15, 2018
ASPET members Amanda Blaker and Dr. Bryan Yamamoto report on the Journal of Neuroimmune Pharmacology that exposure to both alcohol and meth reduces levels of dopamine and serotonin in the brain, two neurotransmitters that control how nerve cells communicate with each other.
August 14, 2018
Parasitic infections can be a nightmare, especially when they interfere with your breathing, eyesight, or digestive tract. But some parasites cause no symptoms in most people with a working immune system.
July 12, 2018
This symposium highlighted the work of scientists Nir Barzilai, Judith Campisi, and Tony Wyss-Coray who are trying to understand what makes a person live longer and to find targets to delay or prevent aging.
June 27, 2018
The urge to enjoy some comfort food or to listen to your favorite song is caused by dopamine- a chemical messenger that neurons release in the brain when you do something you like.
March 27, 2018
For Richard Daneman, the passion for understanding the basic biology of the blood-brain barrier goes back to his graduate school years in Stanford University working alongside his advisor, Dr. Ben Barres.
January 05, 2018
Vanderbilt University scientists Drs. Jeffrey Conn, Paul Newhouse, and Craig W. Lindsley have led a special effort that could benefit patients with Alzheimer’s disease and schizophrenia.